Latest in Ingredients

dsm-firmenich launches pharmaceutical taste solutions portfolio

The range aims to improve the taste and sensory experience of solid, liquid or semi-solid dosage forms

Find out more

You need to be a subscriber to read this article.
Click here to find out more.

Rare diseases: overcoming clinical development challenges with data

From design to patient recruitment, investigator site selection and data interpretation, rare diseases present unique challenges for clinical trials. But, with only 5% of rare...
See more

ABVC BioPharma to invest $220m into US pharmaceutical manufacturing, raw material cultivation

Following its recent $100m pharma manufacturing investment, ABVC plans to integrate its production capacity with new botanical raw material cultivation capacity in the US

dsm-firmenich's CBtru demonstrates similar bioavailability to commercially available Epidiolex

The cannabidiol (CBD)-based drug product intermediate is absorbed into the bloodstream at a similar level compared with the only commercially approved CBD drug, Epidiolex

Indena becomes first API manufacturer to receive European CEP certification

Its CBD extract is the first to receive the European Pharmacopoeia Certificate of Eligibility from the European Directorate for the Quality of Medicines (EDQM)
You need to be a subscriber to read this article.
Click here to find out more.

Beginnings, endings and transitions: Janus and the business of pharmaceuticals

Dr Kevin Robinson recently caught up with pharmaceutical industry experts to review what they considered to be the sector’s key challenges and achievements in 2024 and what trends, technologies or regulatory shifts they anticipate will shape the industry in 2025

Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription

With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence

Europa Biosite acquires life science product and service supplier, AMSBIO

Europa Biosite will now be able to expand its presence across the key US market, while also bolstering its offerings in stem cell research, regenerative medicine and biospecimens

Ingenza and HydRegen collaborate to optimise biomanufacturing sustainability

The companies will work together to optimise and scale HydRegen's range of amine-based biocatalysts, which are more sustainable and cost-effective than traditional metal catalysts

Freeze drying ADCs: points to consider for industrial applications

As antibody-drug conjugates gain momentum in the pharmaceutical industry, manufacturers are increasingly looking to implement safe and effective process trains to produce them. Lyophilisation experts at GEA Pharma & Healthcare assess some of the most critical challenges and how to overcome them

Latest posts in Ingredients

2BScientific expands its life science product supply service to Europe with new German facility

The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies

Rousselot and IamFluidics launch dissolvable microcarrier for cell culturing

The alginate and denatured collagen based product allows researchers to produce scalable cell cultures for biologic drugs and cell therapies

Logical Biological expands its raw pharma material development and supply capabilities with new lab

The raw material supplier can now better serve in vitro diagnostic (IVD) manufacturers, as it has a significantly larger operational capacity

Biosynth inaugurates its Biological Technology site in Suzhou, China

The new site will serve the Chinese domestic market, providing raw materials for vaccines and pharmaceuticals, while dealing regional distribution and handling

Seppic launches surfactant excipient for the optimisation of biological formulations

The ingredient is compatible with sensitive biologics, and aims to stabilise injectables for improved bioavailability, efficacy and shelf life

Beneo presents its taste-boosting excipient, galenIQ at CPHI 2024

galenIQ is designed to improve the flavour of oral solid dosage (OSD) forms for more patient-centric pharmaceuticals

Indena showcases its CDMO services and HPAPI capabilities at CPHI 2024

The company will display its range of high-potency APIs, as well as its ADC and linker payload development and manufacturing capabilities

Clariant introduces new high-performing excipients at the CPHI Milan 2024 trade show

Clariant is excited to present the company’s latest portfolio of products for the healthcare industry at the upcoming CPHI trade show in Milan

IFF Pharma Solutions brings new innovations and excipient excellence to CPHI 2024

IFF Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and biotech industries

Agarose Bead Technologies expands its Spanish agarose resin manufacturing facility

The site is now capable of producing 100,000L of agarose resin per year, which pharma and bioprocessing professionals can use for CGT purification purposes

Bioiberica presents its potent API solutions at CPHI Milan

The company will be on hand to discuss its APIs and ingredients for pharmaceutical products, as well as its circular economy model

dsm-firmenich showcases excipient and sustainability solutions at CPHI Milan

The company will present its range of solutions designed to boost patient compliance, while also exhibiting its pharma-grade CBD ingredient

Sponsor content

C2 PHARMA receives CEP approval for Oxybuprocaine hydrochloride

C2 PHARMA proudly announces the approval of a Certificate of Suitability (CEP) for Oxybuprocaine hydrochloride by the European Directorate for the Quality of Medicines and...

Gelita launches Endotoxin Controlled Excipients for bioscience applications

New portfolio comprises innovative collagen solutions for parenteral applications, medical devices and 3D bioprinting

Therapeutic: felzartamab for kidney disease

Immunoglobulin A nephropathy (IgAN) or Berger disease is the most common form of primary glomerulonephritis and a leading cause of chronic kidney disease

Therapeutic: vimseltinib for tenosynovial giant cell tumour

Tenosynovial giant cell tumour (TGCT) is a rare, non-malignant tumour that results from a translocation in the colony stimulating factor 1 (CSF1) gene

Therapeutic: brensocatib for bronchiectasis

The chronic lung disease bronchiectasis is a serious condition in which the bronchi become permanently dilated because of a cycle of infection, inflammation and damage to...

New small-scale In-Line mixer range from Silverson Machines

Silverson launches versatile small-scale mixers for pharma and biotech applications

Actylis expands into VMS & Pharma with the acquisition of Pharm-Rx

The acquisition strengthens Actylis’ presence in the VMS and OTC markets

Therapeutic: anticancer agent ivonescimab

The advent of PD-1 and PD-L1 targeting antibodies has transformed the outlook for many cancer patients by harnessing the body’s immune system to fight tumour cells

Therapeutic: seladelpar for primary biliary cholangitis

The chronic and progressive autoimmune liver disease, primary biliary cholangitis, affects the bile ducts running through the liver and slowly degrades them

C2 PHARMA marks 10 years at CPHI Milan with expanded ophthalmic APIs

The complany is ready to showcase its expanding ophthalmic API portfolio and global regulatory filings, featuring Naphazoline Hydrochloride and Tropicamide

C2 PHARMA expands ophthalmic API portfolio with Naphazoline Hydrochloride launch

C2 PHARMA, the global leader in ophthalmic and niche active pharmaceutical ingredients (APIs), proudly announces the launch of its latest API, Naphazoline Hydrochloride

Quotient Sciences and Vasa Therapeutics announce dosing of first subjects in VS-041 novel heart failure trial

The trial is designed to evaluate the safety, tolerability, and pharmacokinetics of VS-041 in healthy volunteers

Featured companies

Solvias helps innovative companies advance their path to commercialization with CMC analytical solutions powered by deep scientific expertise and a relentless focus on our... The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech... At Lonza, we enable a healthier world by supporting our healthcare customers on the path to commercialization. Our community of around 17,500 skilled employees work across a... Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway for small-molecule and peptide drug...
See more